نتایج جستجو برای: hbc

تعداد نتایج: 1634  

2015
Quan Yuan Liu-Wei Song Daniela Cavallone Francesco Moriconi Beatrice Cherubini Piero Colombatto Filippo Oliveri Barbara Agata Coco Gabriele Ricco Ferruccio Bonino James Wai Kuo Shih Ning-Shao Xia Maurizia Rossana Brunetto Wenyu Lin

Non invasive immunologic markers of virus-induced liver disease are unmet needs. We tested the clinical significance of quantitative total and IgM-anti-HBc in well characterized chronic-HBsAg-carriers. Sera (212) were obtained from 111 HBsAg-carriers followed-up for 52 months (28-216) during different phases of chronic-HBV-genotype-D-infection: 10 HBeAg-positive, 25 inactive-carriers (HBV-DNA≤2...

Journal: :International journal of molecular medicine 2006
Kazuo Tanaka Yumiko Nagao Tatsuya Ide Ryukichi Kumashiro Michio Sata

Several studies have reported that antibody to hepatitis B core antigen (anti-HBc) positivity may influence the development of hepatocellular carcinoma (HCC) in chronic hepatitis C patients, but the evidence is still not conclusive. In this study, we examined whether the presence of anti-HBc positive was associated with the development of HCC in hepatitis C virus (HCV)-infected subjects among t...

Journal: :Journal of virological methods 2008
Laurence Ollier Catherine Laffont Aurore Kechkekian Alain Doglio Valérie Giordanengo

Routine use of the automated chemiluminescent microparticle immunoassay Abbott ARCHITECT anti-HBc for diagnosis of hepatitis B is limited in case of borderline reactive sera with low signal close to the cut-off index. In order to determine the significance of anti-HBc detection when borderline reactivity occurs using the ARCHITECT anti-HBc assay, a comparative study was designed. 3540 serum sam...

Journal: :Journal of viral hepatitis 2017
J-H Xu L-W Song N Li S Wang Z Zeng C-W Si J Li Q Mao D-Z Zhang H Tang J-F Sheng X-Y Chen Q Ning G-F Shi Q Xie Q Yuan Y-Y Yu N-S Xia

Studies regarding the clinical significance of quantitative hepatitis B core antibody (anti-HBc) in patients with chronic hepatitis B receiving first-line nucleos(t)ide analogues is limited. The aim of this study was to determine the performance of anti-HBc as a predictor for hepatitis B e antigen (HBeAg) seroconversion in HBeAg-positive CHB patients treated with entecavir. This was a retrospec...

Journal: :IOP conference series 2023

Abstract Petung bamboo (Dendrocalamus asper) stem-based hematite-biochar composite (HBC) has been synthesized using microwave-assisted pyrolysis (MAP) to replace conventional pyrolysis. The sawdust contains 19.8-26.6% lignin and cellulose as much 4.24-5.36% so that it can be used precursors in biochar preparation. In general, bamboo-based a low adsorption capacity. this study, was modified by h...

Journal: :Clinical transplantation 2002
Yaw-Sen Chen Chih-Chi Wang Vanessa H de Villa Shih-Hor Wang Yu-Fan Cheng Tung-Liang Huang Bruno Jawan King-Wah Chiu Chao-Long Chen

Exclusion of liver grafts from hepatitis B core antibody (anti-HBc) positive donors to prevent de novo hepatitis B virus (HBV) infection after liver transplantation is not feasible in areas highly endemic for HBV virus like Taiwan, where approximately 80% of adults are anti-HBc(+). The efficacy of lamivudine monotherapy to prevent de novo HBV infection after living donor liver transplantation (...

Journal: :The Journal of clinical investigation 1990
H Skjødt D E Hughes P R Dobson R G Russell

Activated immune cells release cytokines which modulate the activity of bone cells in vitro. Expression of major histocompatibility complex (HLA in humans) class II determinants on bone surface cells may be important in local immune cell activation. In this study, expression of HLA-DR and DQ by cultured human bone cells (HBC) derived from normal trabecular bone surfaces was assessed by fluoresc...

2009
Amitis Ramezani Minoo Mohraz Mohammad Banifazl Ali Eslamifar Arezoo Aghakhani

Background and Objective: Presence of hepatitis B core antibody (anti-HBc) in the absence of hepatitis B surface antigen (HBsAg) and hepatitis B surface antibody (anti-HBs) is defined, as isolated anti-HBc. little is known about the clinical significance of the isolated anti-HBc in hepatitis B virus (HBV) infections. The aim of this study was to assess the significance of anti-HBc as the only m...

2015
Feng-Qin Hou Liu-Wei Song Quan Yuan Lin-Lin Fang Sheng-Xiang Ge Jun Zhang Ji-Fang Sheng Dong-Ying Xie Jia Shang Shu-Huan Wu Yong-Tao Sun Shao-Feng Wei Mao-Rong Wang Mo-Bin Wan Ji-Dong Jia Guang-Han Luo Hong Tang Shu-Chen Li Jun-Qi Niu Wei-dong Zhou Li Sun Ning-Shao Xia Gui-Qiang Wang

A recent study revealed that quantitative hepatitis B core antibody (qAnti-HBc) level could serve as a novel marker for predicting treatment response. In the present study, we further investigated the predictive value of qAnti-HBc level in HBeAg-positive patients undergoing PEG-IFN therapy. A total of 140 HBeAg-positive patients who underwent PEG-IFN therapy for 48 weeks and follow-up for 24 we...

Journal: :Journal of virology 2016
Laurie Ludgate Kuancheng Liu Laurie Luckenbaugh Nicholas Streck Stacey Eng Christian Voitenleitner William E Delaney Jianming Hu

UNLABELLED Multiple subunits of the hepatitis B virus (HBV) core protein (HBc) assemble into an icosahedral capsid that packages the viral pregenomic RNA (pgRNA). The N-terminal domain (NTD) of HBc is sufficient for capsid assembly, in the absence of pgRNA or any other viral or host factors, under conditions of high HBc and/or salt concentrations. The C-terminal domain (CTD) is deemed dispensab...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید